16 Mar 2021

Netherlands suspends use of AstraZeneca vaccine

The Netherlands has joined the Irish Republic, Denmark, Norway, Bulgaria, and Iceland in suspending the administration of the AstraZeneca vaccine. The Democratic Republic of Congo and Indonesia have delayed the beginning of the vaccine rollout whereas Italy and Austria have suspended the use of certain batches as a precautionary measure.

Read More
12 Mar 2021

More European nations pause AstraZeneca vaccine use as blood clot reports investigated

The European Union’s medicines regulator is investigating whether the Oxford-AstraZeneca Covid-19 vaccine could be linked to a number of reports of blood clots. While the investigation is ongoing, Denmark, Iceland and Norway have suspended the use of this vaccine. Denmark announced the two week suspension on Thursday and Iceland and

Read More
17 Feb 2021

South Africa scraps AstraZeneca, pivots to Johnson & Johnson vaccine

South Africa is giving up its stock of Oxford-AstaZeneca Covid-19 vaccines to the African Union and instead is seeking to vaccinate its population with the single-dose Johnson & Johnson drug. The changes in the Covid-19 vaccination policy come after the AstraZeneca vaccine proved to offer minimal protection against the variant

Read More
28 Jan 2021

Germany facing ’10 tough weeks’ of vaccine shortages

Germany is currently facing a shortage of Covid-19 vaccines that could last up to ten weeks, according to the country’s health minister Jens Spahn. The pace of Germany’s vaccine rollout has been less than ideal, failing to meet many of its own daily vaccination targets. Mr. Spahn’s commentary on Twitter

Read More
27 Jan 2021

AstraZeneca-EU row escalates over vaccine shortage

The European Union is calling on pharmaceutical company and vaccine producer AstraZeneca to publish their vaccine contract. The move comes amid frustration at the vaccine vendor due to delivery shortfalls. The EU has been dissatisfied with the production delays but is unable to release details of the deal due to

Read More
30 Nov 2020

The Oxford/AstraZeneca vaccine will be tested in a new trial after questions over its data

The Oxford University and AstraZeneca vaccine will go through another global trial, according to CEO Pascal Soriot. The program had originally been planning to add a subdivision to its existing US trial, however, has decided to re-enter global testing amid criticism over the data to date. The organization has claimed

Read More
23 Nov 2020

The Oxford/AstraZeneca vaccine is up to 90% effective, according to interim data

AstraZeneca and Oxford University’s COVID-19 vaccine has concluded the Phase III trial with a 90% effectiveness rate, according to interim data from the trials. The trial also discovered that the vaccine was only 70% effective when the data of two different dosing regimens were combined. The organizations concluded that the

Read More